PharmTech recently spoke with Beena Wood, chief product officer, Qinecsa Solutions, to get her perspective on trends that shaped pharmaceutical development and manufacturing in 2025 and where things are headed in 2026. In this part 3 of our three-part interview, Wood outlines how 2026 will mark a pivotal year for pharmacovigilance (PV), translational safety, and regulatory innovation, driven by a shift from reactive compliance to proactive, data-enabled decision making. She emphasizes that the industry’s biggest near-term priority is not deploying advanced AI use cases, but building the foundational infrastructure and governance…
